Novo Nordisk A/S (NVO)
43.07
-0.94
(-2.14%)
USD |
NYSE |
Sep 11, 16:00
43.05
-0.02
(-0.05%)
After-Hours: 20:00
Novo Nordisk Price to Book Value : 5.626 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 5.626 |
| September 10, 2026 | 5.748 |
| September 09, 2026 | 5.820 |
| September 08, 2026 | 5.899 |
| September 04, 2026 | 6.087 |
| September 03, 2026 | 6.206 |
| September 02, 2026 | 6.109 |
| September 01, 2026 | 5.894 |
| August 31, 2026 | 5.921 |
| August 28, 2026 | 5.958 |
| August 27, 2026 | 6.042 |
| August 26, 2026 | 6.164 |
| August 25, 2026 | 6.356 |
| August 24, 2026 | 6.129 |
| August 21, 2026 | 6.105 |
| August 20, 2026 | 6.027 |
| August 19, 2026 | 6.071 |
| August 18, 2026 | 5.971 |
| August 17, 2026 | 5.862 |
| August 14, 2026 | 5.994 |
| August 13, 2026 | 6.102 |
| August 12, 2026 | 6.059 |
| August 11, 2026 | 6.161 |
| August 10, 2026 | 6.234 |
| August 07, 2026 | 6.173 |
| Date | Value |
|---|---|
| August 06, 2026 | 6.004 |
| August 05, 2026 | 5.816 |
| August 04, 2026 | 5.784 |
| August 03, 2026 | 6.151 |
| July 31, 2026 | 6.150 |
| July 30, 2026 | 6.741 |
| July 29, 2026 | 6.737 |
| July 28, 2026 | 6.656 |
| July 27, 2026 | 6.488 |
| July 24, 2026 | 6.370 |
| July 23, 2026 | 6.293 |
| July 22, 2026 | 6.294 |
| July 21, 2026 | 6.450 |
| July 20, 2026 | 6.48 |
| July 17, 2026 | 6.573 |
| July 16, 2026 | 6.724 |
| July 15, 2026 | 6.604 |
| July 14, 2026 | 6.410 |
| July 13, 2026 | 6.437 |
| July 10, 2026 | 6.463 |
| July 09, 2026 | 6.385 |
| July 08, 2026 | 6.386 |
| July 07, 2026 | 6.484 |
| July 06, 2026 | 6.434 |
| July 02, 2026 | 6.587 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.50 |
| GSK Plc | 4.157 |
| Johnson & Johnson | 7.527 |
| Eli Lilly & Co. | 31.01 |
| Merck & Co., Inc. | 8.473 |
Price to Book Value Related Metrics
| PE Ratio | 10.53 |
| PS Ratio | 3.721 |
| PEG Ratio | 0.8353 |
| Price to Free Cash Flow | 25.47 |
| Price | 43.07 |
| Earnings Yield | 9.50% |
| Market Cap | 144.11B |
| PEGY Ratio | 0.6276 |
| Operating PE Ratio | 8.201 |
| Normalized PE Ratio | 10.12 |